Veteran manga artist and illustrator Hisashi Eguchi (69), known for hit works such as Stop!! Hibari-kun!, is under intense criticism after being accused of tracing a third party’s photograph without permission for a commercial illustration.
Two white three-story school buildings stood quietly at the foot of the mountains, while cicadas cried loudly in the background complementing the summer heat.
On April 8, 2025, Japan’s regenerative medicine reached a historic turning point. Cuorips Inc., a biotech venture spun out of Osaka University, announced it had submitted a marketing authorization application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for a “cardiomyocyte sheet” created from human induced pluripotent stem (iPS) cells. This is believed to be the world’s first marketing application aiming to commercialize a regenerative medicine product using iPS cells, and it has generated great anticipation across the scientific and medical communities.